Myocardial Salvage
2006; Lippincott Williams & Wilkins; Volume: 113; Issue: 15 Linguagem: Catalão
10.1161/circulationaha.105.618942
ISSN1524-4539
Autores Tópico(s)Coronary Interventions and Diagnostics
ResumoHomeCirculationVol. 113, No. 15Myocardial Salvage Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBMyocardial SalvageRetrospection, Resolution, and Radio Waves Dudley Pennell Dudley PennellDudley Pennell From the Department Cardiology, National Heart and Lung Institute, Imperial College, London, UK. Originally published18 Apr 2006https://doi.org/10.1161/CIRCULATIONAHA.105.618942Circulation. 2006;113:1821–1823Cardiovascular magnetic resonance (CMR) is established as a major technique in clinical cardiology.1 An ongoing pipeline of new clinical indications is being fed from clinical and basic research that is throwing new light on pathophysiology of cardiovascular disease and solving clinical problems. One such advance in the last 5 years has been the clinical uptake of late-gadolinium-enhancement CMR, which yields exquisite high-resolution imaging of infarction in the necrotic (acute) or scarred (chronic) phase,2 making CMR the clinical gold standard technique for assessing infarct size3 and valuable for assessing potential regional functional recovery (viability).4 In this issue, Aletras et al5 indicate that CMR also may be used to measure myocardial salvage during acute infarction.Article p 1865Myocardial salvage is defined as the difference between the actual and potential infarct size, the latter defined as the initial area at risk during acute coronary occlusion. It is an important concept because its measurement can be used to determine strategies to optimize management of acute myocardial infarction (MI) based on the idea that eventual clinical outcome is related to the size of infarction and that minimization is therefore beneficial. Clinical trials of minimization of infarction have a long and distinguished pedigree.6 Myocardial salvage can be measured in several ways, but some are applicable to individuals and others only to groups of patients. Thus, an intervention in acute MI can be tested for benefit by randomization of a cohort of patients to intervention or not, with follow-up of final infarct size surrogates such as ejection fraction or enzyme release. Alternatively, the same intervention can be tested for its direct effect on salvage, which allows assessment of the individual response in relation to the outcome variables and group outcomes. This strategy allows a much clearer assessment of confounding factors; thus, direct measures of salvage are attractive both scientifically and for clinical practice in individuals.The most widely practiced technique for directly measuring myocardial salvage currently is single photon emission tomography imaging with a technetium perfusion tracer that can be injected during coronary occlusion.7 Prolonged myocardial tracer residence with minimal redistribution allows imaging of the area at risk several hours after the acute presentation and even after clinical interventions, because the image will represent tracer uptake at the time of injection, with the defect representing area at risk. A subsequent predischarge rest perfusion scan identifies the final infarction size, which is smaller than the area at risk if myocardial salvage has occurred. This approach has been applied very successfully in trials, particularly those from the Mayo Clinic8 and Munich,9 and has confirmed that the degree of myocardial salvage is an independent predictor of outcome.10 However, the logistics of such investigations, particularly the initial single photon emission tomography study representing the area at risk, are formidable for multicenter trials. In particular, the tracer (6-hour half-life) must be available at all times for immediate injection during coronary occlusion before any intervention, injection should be performed in line with radiation safety guidelines, and good-quality imaging of the area at risk needs to be completed at each participating center within 8 hours, which poses problems at night. Aletras et al5 suggest that T2 CMR might serve as an alternative means of assessing the area at risk, with the notable feature of decoupling the imaging for some days after the acute presentation (retrospection). Late-gadolinium-enhancement CMR can be used to depict the final infarct size and thence myocardial salvage by subtraction.There are a number of questions to address in relation to the interpretation of T2 CMR in the setting of acute infarction: What is T2; how is it measured; how well described is the occurrence, distribution, and severity of edema in infarction; what does the T2 signal increase in infarction mean; how well validated is the T2 disturbance in relation to the area at risk; how long does the increased T2 signal last; and what is the relation of the T2 high signal area and that of late gadolinium enhancement? Despite gaps in our knowledge, the overall understanding of the answers to these questions is quite reasonable.Tissue T2 is a measurable property describing 1 aspect of magnetic relaxation that is directly affected by changes in tissue biochemistry, especially tissue water.11 This suggests that increasing T2 should be useful in identifying edema. Other influences on myocardial T2 are changes in proteins during ischemia (such as cross-linking) and reperfusion, which may affect the time to appearance and the intensity of T2 change. T2 can be imaged by CMR in standard magnets using standard T2-weighted acquisitions, and image analysis is simply based on identifying increased regional signal intensity. Recent literature on edema in acute MI is not abundant, and quantification is difficult because of fixation artifact and other factors in histological studies. Peri-infarction edema is well recognized, however, and older reports of infarction indicate a 25% increase in myocardial water content, regional swelling, and transmural distribution of edema.12,13 T2 CMR studies also show transmural T2 signal increases in acute infarction, even in those infarctions that ultimately show subendocardial scar.14–16 This lends credence to the concept that the distribution of T2 signal abnormality exceeds that of scar and represents the nonlethal injury zone (the area at risk) during acute coronary occlusion in humans, which is in accordance with animal experiments.13,17 Also consistent with these interpretations is the reduction in T2 seen with successful treatment of myocardial edema with mannitol.18 The increase in T2 observed with edema takes a minimum of 1 hour to be manifest in humans,19 can be identified in dogs within 4 hours,20 and only completely resolves some months later.15 One question that has been raised regarding MI imaging by late-gadolinium-enhancement CMR is whether in the acute setting the gadolinium enhancement is confined to the necrotic area or whether extension occurs into the border zone of myocardial edema without necrosis, which might have increased interstitial space that could harbor gadolinium. The study by Aletras et al5 firmly answers this question and demonstrates that late gadolinium enhancement is limited to the area of necrosis only. The lack of increased gadolinium signal in the border zone indicates that its partition coefficient must be similar to normal myocardium and less than within the area of necrosis, which is in accordance with experimental evidence.21 This can be reconciled if there is balanced intracellular and extracellular edema occurring in the border zone.21–23CMR is not the only technique that can identify ischemia in retrospect. In nuclear cardiology, the fatty acid tracer 123I-β-methyl-p-iodophenyl-pentadecanoic acid (BMIPP) also has similar properties, and the mechanism appears to be due mainly to a metabolic imprint related to a persistent decrease in β-oxidation with increased shunt retention of BMIPP in the triglyceride pool.24 This tracer has been evaluated extensively in Japan25 and more recently in the United States26 and has attracted the label of an ischemic memory tracer. This property can be exploited during exercise testing with favorable comparison to thallium26 or in the acute infarction setting to determine the area at risk well after the coronary occlusion.27 A single study comparing BMIPP and T2 CMR in humans with acute infarction showed T2 CMR to have improved accuracy for identifying culprit lesions.28 The positron emission tracer 19F-fluorodeoxyglucose also shows persistent glucose metabolism derangement after ischemia.29 Studies comparing the area at risk between T2 CMR and these tracers would be of interest.One issue that has arisen is the confidence with which the area at risk can be demarcated with T2 CMR, which depends on the contrast that exists between normal and at-risk myocardium and the robustness of the technique. T2 CMR can be performed using breathholds typically 12 hours after onset of symptoms, for whom primary angioplasty is not an automatic choice. The issue in such patients is to individualize the decision to proceed. It is possible to imagine patients at this stage whose coronary artery has been continuously occluded and whose infarction wave front has virtually reached the border of the area at risk. Another patient, however, may have intermittent coronary occlusion; for this patient, periodic perfusion, ischemia, and infarction could result in stuttering infarction that might leave substantial salvageable myocardium. It is reasonable to consider that the latter patient has something to gain from late immediate angioplasty.In addition, adjunctive treatments to reperfusion therapies remain of considerable interest. These typically will require considerable resources to study and a multicenter approach in clinical trials. CMR assessment of myocardial salvage is attractive for a number of reasons in this setting. First, the requirement for 24-hour immediate availability in the emergency room of technetium myocardial perfusion tracer is obviated. Second, image resolution is substantially improved, leading to higher-fidelity measurements and thus smaller sample sizes. Third, it would be entirely possible to operate a hub-and-spoke model for the CMR scans, with a number of participating hospitals that might not have sufficient CMR expertise or availability contributing patients to a nearby hub expert center for predischarge assessment of salvage. Fourth, an important ethical consideration for such research is that the radiation burden of nuclear studies can be avoided.In conclusion, the experimental understanding from animal studies for the use of CMR to assess myocardial salvage is sound, and translation into human studies is likely with improved methodology. This includes improving T2 image contrast through sequence optimization and defining the optimal timing for T2 imaging in humans. Also of value would be evaluating the T2 response to infarction in the presence and absence of reperfusion, evaluating the myocardial T2 response to exercise-induced ischemia, and clinical experience. Using CMR for clinical myocardial salvage studies appears eminently feasible and is logistically attractive.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.DisclosuresNone.FootnotesCorrespondence to Dr Dudley Pennell, Director, Cardiovascular MR Unit, Royal Brompton Hospital, Sydney St, London SW3 6NP, UK. E-mail [email protected] References 1 Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004; 25: 1940–1965.CrossrefMedlineGoogle Scholar2 Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100: 1992–2002.CrossrefMedlineGoogle Scholar3 Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003; 361: 374–379.CrossrefMedlineGoogle Scholar4 Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 16: 1445–1453.Google Scholar5 Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF, Arai AE. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006; 113: 1865–1870.LinkGoogle Scholar6 Maroko PR, Libby P, Bloor CM, Sobel BE, Braunwald E. Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation. 1972; 46: 430–437.CrossrefMedlineGoogle Scholar7 Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B, Bolli R. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol. 1988; 12: 1573–1581.CrossrefMedlineGoogle Scholar8 Milavetz JJ, Giebel DW, Christian TF, Schwartz RS, Holmes DR Jr, Gibbons RJ. Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol. 1998; 31: 1246–1251.CrossrefMedlineGoogle Scholar9 Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R, Seyfarth M, Schwaiger M, Schomig A, for the Stent Versus Thrombolysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction (STOPAMI-2) Study. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet. 2002; 359: 920–925.CrossrefMedlineGoogle Scholar10 Ndrepepa G, Mehilli J, Schwaiger M, Schuhlen H, Nekolla S, Martinoff S, Schmitt C, Dirschinger J, Schomig A, Kastrati A. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med. 2004; 45: 725–729.MedlineGoogle Scholar11 Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1–100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med Phys. 1984; 11: 425–448.CrossrefMedlineGoogle Scholar12 Reimer KA, Jennings RB. The changing anatomic reference base of evolving myocardial infarction: underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation. Circulation. 1979; 60: 866–876.CrossrefMedlineGoogle Scholar13 Garcia-Dorado D, Oliveras J, Gili J, Sanz E, Perez-Villa F, Barrabes J, Carreras MJ, Solares J, Soler-Soler J. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res. 1993; 27: 1462–1469.CrossrefMedlineGoogle Scholar14 Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, Gross M, Dietz R, Friedrich MG. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004; 109: 2411–2416.LinkGoogle Scholar15 Nilsson JC, Nielsen G, Groenning BA, Fritz-Hansen T, Sondergaard L, Jensen GB, Larsson HB. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart. 2001; 85: 639–642.CrossrefMedlineGoogle Scholar16 Johnston DL, Mulvagh SL, Cashion RW, O'Neill PG, Roberts R, Rokey R. Nuclear magnetic resonance imaging of acute myocardial infarction within 24 hours of chest pain onset. Am J Cardiol. 1989; 64: 172–179.CrossrefMedlineGoogle Scholar17 Tilak GS, Hsu LY, Arai AE, Aletras AH. T2 weighted cardiac magnetic resonance imaging delineates area at risk in the absence of reperfusion injury 2 days post-infarction. J Cardiovasc Magn Reson. 2006; 8: 272. Abstract.Google Scholar18 Miller DD, Johnston DL, Dragotakes D, Newell JB, Aretz T, Kantor HL, Brady TJ, Okada RD. Effect of hyperosmotic mannitol on magnetic resonance relaxation parameters in reperfused canine myocardial infarction. Magn Reson Imaging. 1989; 7: 79–88.CrossrefMedlineGoogle Scholar19 Schulz-Menger J, Gross M, Messroghli D, Uhlich F, Dietz R, Friedrich MG. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol. 2003; 42: 513–518.CrossrefMedlineGoogle Scholar20 Angelos MG, Katz-Stein A, Leasure JE. Early detection of myocardial infarction with magnetic resonance imaging in a canine model. Ann Emerg Med. 1993; 22: 1378–1384.CrossrefMedlineGoogle Scholar21 Li G, Xiang B, Dai G, Shaw A, Liu H, Yang B, Jackson M, Deslauriers R, Tian G. Tissue edema does not change gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)-enhanced T1 relaxation times of viable myocardium. J Magn Reson Imaging. 2005; 21: 744–751.CrossrefMedlineGoogle Scholar22 Willerson JT, Scales F, Mukherjee A, Platt M, Templeton GH, Fink GS, Buja LM. Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol. 1977; 87: 159–188.MedlineGoogle Scholar23 Kim RJ, Judd RM, Chen EL, Fieno DS, Parrish TB, Lima JA. Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. Circulation. 1999; 100: 185–192.CrossrefMedlineGoogle Scholar24 Hosokawa R, Nohara R, Hirai T, Fujibayashi Y, Fujita M, Kambara N, Ohba M, Tadamura E, Kimura T, Kita T. Myocardial metabolism of 123I-BMIPP under low-dose dobutamine infusion: implications for clinical SPECT imaging of ischemic heart disease. Eur J Nucl Med Mol Imaging. 2005; 32: 75–83.CrossrefMedlineGoogle Scholar25 Hasegawa S, Kusuoka H, Fukuchi K, Hori M, Nishimura T. Estimation of the area at risk in myocardial infarction of rats by means of I-123 beta-methyliodophenyl pentadecanoic acid imaging. Ann Nucl Med. 2000; 14: 347–352.CrossrefMedlineGoogle Scholar26 Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram MY, Goodbody AE, Babich JW, Udelson JE. Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation. 2005; 112: 2169–2174.LinkGoogle Scholar27 Mochizuki T, Murase K, Higashino H, Miyagawa M, Sugawara Y, Kikuchi T, Ikezoe J. Ischemic "memory image" in acute myocardial infarction of 123I-BMIPP after reperfusion therapy: a comparison with 99mTc-pyrophosphate and 201Tl dual-isotope SPECT. Ann Nucl Med. 2002; 16: 563–568.CrossrefMedlineGoogle Scholar28 Takahashi N, Inoue T, Oka T, Suzuki A, Kawano T, Uchino K, Mochida Y, Ebina T, Matumoto K, Yamakawa Y, Umemura S. Diagnostic use of T2-weighted inversion-recovery magnetic resonance imaging in acute coronary syndromes compared with 99mTc-pyrophosphate, 123I-BMIPP, and 201TlCl single photon emission computed tomography. Circ J. 2004; 68: 1023–1029.CrossrefMedlineGoogle Scholar29 Di Carli MF, Prcevski P, Singh TP, Janisse J, Ager J, Muzik O, Vander Heide R. Myocardial blood flow, function, and metabolism in repetitive stunning. J Nucl Med. 2000; 41: 1227–1234.MedlineGoogle Scholar30 Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215–223.CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Xu F, Luo C, Li M, Guan K, Peng F, Yang G and Peng P (2023) Quantification of cardiac iron in patients with thalassemia with 3-T MRI calibrated by 1.5-T MRI, Acta Radiologica, 10.1177/02841851231165283, 64:6, (2096-2103), Online publication date: 1-Jun-2023. Li Y, Wang G, Wang X, Li Y, Zhao Y, Gu X, Xu B, Cui J, Wang X, Sun Y, Liu S and Yu B (2022) Prognostic significance of myocardial salvage assessed by cardiac magnetic resonance in reperfused ST-segment elevation myocardial infarction, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.924428, 9 Zhang S, Ma Q, Jiao Y, Wu J, Yu T, Hou Y, Sun Z, Zheng L and Sun Z (2022) Prognostic value of myocardial salvage index assessed by cardiovascular magnetic resonance in reperfused ST-segment elevation myocardial infarction, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.933733, 9 Rios-Navarro C, Ortega M, Marcos-Garces V, Gavara J, de Dios E, Perez-Sole N, Chorro F, Bodi V and Ruiz-Sauri A (2020) Interstitial changes after reperfused myocardial infarction in swine: morphometric and genetic analysis, BMC Veterinary Research, 10.1186/s12917-020-02465-6, 16:1, Online publication date: 1-Dec-2020. Feger J (2020) Myocardial salvage Radiopaedia.org, 10.53347/rID-78962 Ieroncig F, Breau J, Bélair G, David L, Noiseux N, Hatem R and Avram R (2019) Novel Approaches to Define Outcomes in Coronary Revascularization, Canadian Journal of Cardiology, 10.1016/j.cjca.2018.12.016, 35:8, (967-982), Online publication date: 1-Aug-2019. Demirkiran A, Everaars H, Amier R, Beijnink C, Bom M, Götte M, van Loon R, Selder J, van Rossum A and Nijveldt R (2019) Cardiovascular magnetic resonance techniques for tissue characterization after acute myocardial injury, European Heart Journal - Cardiovascular Imaging, 10.1093/ehjci/jez094, 20:7, (723-734), Online publication date: 1-Jul-2019. Hausenloy D, Lim M, Chan M, Paradies V, Francis R, Kotecha T, Knight D, Fontana M, Kellman P, Moon J and Bulluck H (2019) Interrogation of the infarcted and salvaged myocardium using multi-parametric mapping cardiovascular magnetic resonance in reperfused ST-segment elevation myocardial infarction patients, Scientific Reports, 10.1038/s41598-019-45449-9, 9:1 Alkhalil M and Dall'Armellina E (2018) Myocardial Viability in Ischaemic Heart Disease Protocols and Methodologies in Basic Science and Clinical Cardiac MRI, 10.1007/978-3-319-53001-7_11, (347-384), . Saeed M, Liu H, Liang C and Wilson M (2017) Magnetic resonance imaging for characterizing myocardial diseases, The International Journal of Cardiovascular Imaging, 10.1007/s10554-017-1127-x, 33:9, (1395-1414), Online publication date: 1-Sep-2017. Bulluck H, Bryant J, Lim M, Tan X, Ramlall M, Francis R, Kotecha T, Cabrera-Fuentes H, Knight D, Fontana M, Moon J and Hausenloy D (2017) Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mapping, Scientific Reports, 10.1038/s41598-017-05127-0, 7:1 Layland J, Rauhalammi S, Lee M, Ahmed N, Carberry J, Teng Yue May V, Watkins S, McComb C, Mangion K, McClure J, Carrick D, O'Donnell A, Sood A, McEntegart M, Oldroyd K, Radjenovic A and Berry C (2017) Diagnostic Accuracy of 3.0‐T Magnetic Resonance T1 and T2 Mapping and T2‐Weighted Dark‐Blood Imaging for the Infarct‐Related Coronary Artery in Non–ST‐Segment Elevation Myocardial Infarction, Journal of the American Heart Association, 6:4, Online publication date: 5-Apr-2017. Basha T, Bellm S, Roujol S, Kato S and Nezafat R (2015) Free-breathing slice-interleaved myocardial T 2 mapping with slice-selective T 2 magnetization preparation , Magnetic Resonance in Medicine, 10.1002/mrm.25907, 76:2, (555-565), Online publication date: 1-Aug-2016. Bulluck H, Rosmini S, Abdel‐Gadir A, White S, Bhuva A, Treibel T, Fontana M, Gonzalez‐Lopez E, Reant P, Ramlall M, Hamarneh A, Sirker A, Herrey A, Manisty C, Yellon D, Kellman P, Moon J and Hausenloy D (2016) Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post–Reperfused ST‐Elevation Myocardial Infarction, Journal of the American Heart Association, 5:7, Online publication date: 6-Jul-2016. Mangion K, Corcoran D, Carrick D and Berry C (2016) New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction, Expert Review of Cardiovascular Therapy, 10.1586/14779072.2016.1173544, 14:7, (843-854), Online publication date: 2-Jul-2016. Dastidar A, Rodrigues J, Baritussio A and Bucciarelli-Ducci C (2015) MRI in the assessment of ischaemic heart disease, Heart, 10.1136/heartjnl-2014-306963, 102:3, (239-252), Online publication date: 1-Feb-2016. Khan J, Nazir S, Horsfield M, Singh A, Kanagala P, Greenwood J, Gershlick A and McCann G (2015) Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths, BMC Research Notes, 10.1186/s13104-015-1007-1, 8:1, Online publication date: 1-Dec-2015. Fernández-Jiménez R, Sánchez-González J, Aguero J, del Trigo M, Galán-Arriola C, Fuster V and Ibáñez B (2015) Fast T2 gradient-spin-echo (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion, Journal of Cardiovascular Magnetic Resonance, 10.1186/s12968-015-0199-9, 17:1, Online publication date: 1-Dec-2015. Bulluck H, White S, Rosmini S, Bhuva A, Treibel T, Fontana M, Abdel-Gadir A, Herrey A, Manisty C, Wan S, Groves A, Menezes L, Moon J and Hausenloy D (2015) T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients, Journal of Cardiovascular Magnetic Resonance, 10.1186/s12968-015-0173-6, 17:1, Online publication date: 1-Dec-2015. Perea Palazón R, Solé Arqués M, Prat González S, de Caralt Robira T, Cibeira López M and Ortiz Pérez J (2015) Parametric methods for characterizing myocardial tissue by magnetic resonance imaging (part 2): T2 mapping, Radiología (English Edition), 10.1016/j.rxeng.2015.09.003, 57:6, (471-479), Online publication date: 1-Nov-2015. Perea Palazón R, Solé Arqués M, Prat González S, de Caralt Robira T, Cibeira López M and Ortiz Pérez J (2015) Técnicas paramétricas de caracterización tisular del miocardio mediante resonancia magnética (parte 2): mapas de T2, Radiología, 10.1016/j.rx.2015.05.002, 57:6, (471-479), Online publication date: 1-Nov-
Referência(s)